Sleep Well At Night
Launched by OUR LADY'S HOSPICE AND CARE SERVICES · Jul 7, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Advances in cancer treatments have improved prognosis for many patients, placing a heightened demand on clinical care to provide quality of life as well as quantity of life. Individuals with advanced cancer face progressive symptoms that are a major source of suffering and impairment. Sleep disturbance is a prevalent, but often overlooked symptom, affecting up to 96% of patients with advanced cancer. While there are multiple types of sleep disorders affecting patients with advanced cancer, insomnia seems to be the most prevalent sleep disorder in this patient cohort, occurring at various po...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years old and over
- • 2. Diagnosis of advanced cancer (locally advanced, metastatic)
- • 3. Subjective sleep disturbance
- • 4. Total score of 5 or more on PSQI
- • 5. Eastern Cooperative Oncology Group (ECOG) performance status 1-3
- • 6. Attending outpatients (oncology and/or palliative care)
- • 7. Estimated prognosis of \> 3 months
- Exclusion Criteria:
- • 1. Inpatient
- • 2. ECOG performance status 4
- • 3. Cognitive impairment limiting the ability to complete assessment tools and sleep diary
- • 4. Engaged in shift work
- • 5. A recent exacerbation of symptoms (e.g. pain/nausea/dyspnoea) which may impact sleep
- • 6. History of uncontrolled mania or bipolar disorder
- • 7. Recent history or current thoughts of self-harm or suicide
- • 8. Recent change in antidepressant medication
About Our Lady's Hospice And Care Services
Our Lady's Hospice and Care Services is a leading healthcare provider dedicated to delivering exceptional palliative and end-of-life care. With a commitment to enhancing the quality of life for patients and their families, the organization integrates compassionate clinical support with innovative research initiatives. By sponsoring clinical trials, Our Lady's Hospice aims to advance medical knowledge and improve therapeutic options in palliative care, ensuring that patients receive the most effective treatments tailored to their individual needs. Through collaboration with healthcare professionals and research institutions, the organization strives to foster a holistic approach to care that prioritizes dignity, comfort, and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, , Ireland
Patients applied
Trial Officials
Professor Andrew Davies
Principal Investigator
Our Lady's Hospice & Care Services
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported